Aurovela 1/20 Tablet
Product Images NDC 65862-939

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Aurovela 1/20 (NDC 65862-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindroneethinyl Fig1)

A bar chart illustrating circulatory disease mortality rates per 100,000 woman years by age group (15-24, 25-34, 35-44, 45-) and smoking status among oral contraceptive users and controls. Mortality rates are shown for ever-users (non-smokers and smokers) and controls (non-smokers and smokers), with smokers who are ever-users having notably higher mortality rates, especially in older age groups.*

FDA Label Image

Blister Pack (Norethindroneethinyl Fig2)

A forest plot chart comparing 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' from various studies. It presents effect estimates (OR, RR, HR) with confidence intervals depicted as horizontal lines around points, plotted on a scale from -1.5 to 2.0.*

FDA Label Image

Blister Pack (Norethindroneethinyl Fig3)

Instructional diagram for Aurovela 1/20 tablets showing a 3-week calendar layout with days of the week labeled from Sunday to Saturday. It guides users to start on Sunday for both Sunday starters and Day-1 starters, with an additional note for Day-1 starters to place a day label sticker corresponding to the first day of their period if it begins on a day other than Sunday.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Label)

An illustrated medication calendar chart for Aurovela 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) showing three rows representing weeks and days of the week labeled Sunday through Saturday. The chart includes instructions for "Day-1 Starters" to place a day label sticker starting with the first day of their period if it begins on a day other than Sunday, and for both Sunday Starters and Day-1 Starters to start on the first Sunday circle in the chart's first week.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Carton)

The packaging label for Aurovela 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) shows a 21-tablet pouch for a 21-day regimen. Each tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol. The label includes clear dosage information, manufacturer and distributor details, a barcode, and a pharmacy label area. The product is for oral use and prescription only, distributed by Aurobindo Pharma USA Inc.*

FDA Label Image

Norethindroneethinyl Fig6

The packaging label for Aurovela 1/20 tablets contains the proprietary name and active ingredients Norethindrone Acetate and Ethinyl Estradiol USP. It specifies the dosage form as tablets in a 21-day regimen, with 5 blister packs each holding 21 light yellow tablets (1 mg norethindrone acetate, 20 mcg ethinyl estradiol). The label includes storage directions, warnings, and distributor information from Aurobindo Pharma USA, Inc. The package is marked Rx only and notes the product is made in India.*

FDA Label Image

Chemical Structure1 (Norethindroneethinyl Str1)

Chemical structure of Norethindrone Acetate, the active ingredient in Aurovela 1/20 tablets. The diagram depicts the molecular arrangement including rings and functional groups relevant to norethindrone acetate.*

FDA Label Image

Chemical Structure2 (Norethindroneethinyl Str2)

Chemical structure of Ethinyl Estradiol, as shown in the diagram, highlighting the molecular framework of the active ingredient in Aurovela 1/20 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.